SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Mahdiyar Pouresmaeeli, Seyed Moayed Alavian, Maryam Keshvari, Shima Salimi, Leila Mehrnoush, Efficacy and Tolerability of Peginterferon alpha-2a and Peginterferon alpha-2b in Iranian Patients With Chronic Hepatitis C, Hepatitis Monthly, 2015, 15, 9

    CrossRef

  2. 2
    P. A. Cortesi, A. Ciaccio, M. Rota, J. K. Lim, S. De Salvia, S. Okolicsanyi, M. Vinci, L. S. Belli, L. G. Mantovani, M. Strazzabosco, Management of treatment-naïve chronic hepatitis C genotype 1 patients: a cost-effectiveness analysis of treatment options, Journal of Viral Hepatitis, 2015, 22, 2
  3. 3
    Clara T. M. M. de Kanter, Joost P. H. Drenth, Joop E. Arends, Henk W. Reesink, Marc van der Valk, Robert J. de Knegt, David M. Burger, Viral Hepatitis C Therapy: Pharmacokinetic and Pharmacodynamic Considerations, Clinical Pharmacokinetics, 2014, 53, 5, 409

    CrossRef

  4. 4
    R. Ravasio, R. Tomic, B. Deodato, R. Bruno, Analisi di cost-consequence della duplice e triplice terapia nel trattamento dell’epatite cronica di tipo C genotipo 1 in pazienti adulti naïve con fibrosi F0–F2, PharmacoEconomics Italian Research Articles, 2013, 15, 3, 111

    CrossRef